↓ Skip to main content

Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment

Overview of attention for article published in Molecular Oncology, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
20 X users
patent
6 patents

Readers on

mendeley
99 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment
Published in
Molecular Oncology, January 2022
DOI 10.1002/1878-0261.13146
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 99 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 12 12%
Student > Ph. D. Student 8 8%
Student > Master 6 6%
Student > Bachelor 5 5%
Other 3 3%
Other 10 10%
Unknown 55 56%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 18%
Immunology and Microbiology 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Medicine and Dentistry 4 4%
Agricultural and Biological Sciences 2 2%
Other 7 7%
Unknown 58 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2026.
All research outputs
#2,216,368
of 32,876,213 outputs
Outputs from Molecular Oncology
#102
of 2,062 outputs
Outputs of similar age
#44,539
of 559,259 outputs
Outputs of similar age from Molecular Oncology
#3
of 51 outputs
Altmetric has tracked 32,876,213 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,062 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 559,259 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.